Michael May | Centre for Commercialization of Regenerative Medicine
July 16th 2024 - From the archives, our guest this week is Michael May, President and CEO of the Centre for Commercialization of Regenerative Medicine. Michael is someone I've had the pleasure of meeting on a number of occasions and he's one of those people you just know you're going to like. He's focused, incredibly generous with his time, and one of the true national leaders in Canada's life sciences community. Michael's story is similar to many of the guests we've had on our show in that it's not a linear path nor was it planned. You'll hear that his success is based on hard work, being open to opportunity when it presents itself, and sometimes learning life lessons from family pets.
CCRM: ccrm.ca
Get Your Tickets to The NGBI Summit: nextgreatbigideas.com
Lab Occupier: laboccupier.com
Creators and Guests
![Jim Wilson](https://img.transistor.fm/KYFnwQPM0_PP5A3kMQFS7WCVJrqG38b9pbrdqvO18vI/rs:fill:400:400:1/q:60/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.webp)
Host
Jim Wilson
Jim Wilson has 35 years of experience in commercial real estate and leads a contract real estate team working exclusively with Tenants in Canadian Life Sciences. He is the founder and Chair of www.NextGreatBigIdeas.com - Canada's Life Sciences Summit and the host of the NGBIdeas & NGBI Lab podcasts.
![Michael May](https://img.transistor.fm/lCkIiuuui8Zxcrh9h-W3Kddt3UMBParcrhTfPkKvFWQ/rs:fill:400:400:1/q:60/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81YjA1/YTA0ZWUzMTBjZGQ4/ZDlmYzA1ZmU3YjI0/YWY4NC5qcGc.webp)
Guest
Michael May
Michael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM), a Canadian, not-for-profit that develops technologies, launches new companies and catalyzes investment in the field of regenerative medicine, including cell and gene therapy. Prior to CCRM, Michael was the President, and co-founder, of Rimon Therapeutics Ltd., a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity.
![Michael May | Centre for Commercialization of Regenerative Medicine](https://img.transistor.fm/c33zYHjuHXlpcLTzHfei0aDFFL4GHfkv8hFeDp2YBb0/rs:fill:800:800:1/q:60/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zNGFi/ZTY0MTAzNjAzYWRj/MmMyYjQ4ZWM5Mzc2/NzQ1My5wbmc.webp)